Clinical Trial: Creatinine-Body Weight Ratio as a Predictor of Hepatic Steatosis in Patients With Metabolic Syndrome

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780253) titled 'Creatinine-Body Weight Ratio as a Predictor of Hepatic Steatosis in Patients With Metabolic Syndrome' on Aug. 19.

Brief Summary: Metabolic syndrome is a major global health burden characterized by a clustering of metabolic abnormalities including central obesity, hypertension, dyslipidaemia, and impaired glucose metabolism. Recent modelling data indicated that the worldwide prevalence of metabolic syndrome doubled between 2000 and 2023, reaching approximately 31% among women and 26% among men, with an estimated 1.54 billion adults affected globally [1].

In the Middle East and North Africa region, the prevalence of metabolic syndrom...